AzTrials
AzTrials

Low Back PainNCT03333213

Gua Sha Therapy for Chronic Low Back Pain

A study testing Gua Sha in people with Low Back Pain, run by Universität Duisburg-Essen.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic low back pain is a major public health burden with only limited evidence of effectiveness for complementary and traditional therapies. Gua Sha is a traditional East Asian therapy traditionally used in the treatment of spinal pain. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Low Back Pain
What is being tested?
Gua Sha
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
No sites listed yet
Study dates
1 Jan 2009to 1 Dec 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • non-specific low back pain at least once weekly for at least the previous 3 months
  • average back pain intensity hat least 40mm on a 100mm visual analog scale (VAS)

Who cannot join

  • specific low back pain due to trauma, disc protrusion, whiplash, congenital deformity of the spine, spinal stenosis, neoplasm, inflammatory rheumatic disease, or oncologic disease
  • dystonia
  • pregnancy
  • invasive treatment of the spine or spinal surgery within the previous 4 weeks
  • oral steroids or anticoagulants
  • hemophilia or a skin condition in the area to be treated
  • started a new treatment for low back pain within the previous month or planning to start a new treatment within the next month

About this study

Official title: Gua Sha Therapy for Chronic Low Back Pain: a Randomized Controlled Trial

Chronic low back pain is a major public health burden with only limited evidence of effectiveness for complementary and traditional therapies. Gua Sha is a traditional East Asian therapy traditionally used in the treatment of spinal pain. This study aimed to test the efficacy of Gua Sha therapy in patients with chronic low back pain A total of 50 patients with chronic low back pain were randomized to either two Gua Sha treatments (n=25) or a waitlist control group (n=25). Primary outcome measure was current pain intensity on a 100-mm visual analog scale; secondary outcome measures included back-related function (Oswestry Disability Index), movement-related pain (modified Pain on Movement Questionnaire), as well as pressure pain threshold, mechanical detection threshold, and vibration detection threshold.

Read the detailed description

Chronic low back pain is a major public health burden with only limited evidence of effectiveness for complementary and traditional therapies. Gua Sha is a traditional East Asian therapy traditionally used in the treatment of spinal pain. This study aimed to test the efficacy of Gua Sha therapy in patients with chronic low back pain A total of 50 patients with chronic low back pain were randomized to either two Gua Sha treatments (n=25) or a waitlist control group (n=25). Primary outcome measure was current pain intensity on a 100-mm visual analog scale; secondary outcome measures included back-related function (Oswestry Disability Index), movement-related pain (modified Pain on Movement Questionnaire), as well as pressure pain threshold, mechanical detection threshold, and vibration detection threshold.

Conditions
Low Back Pain
Being tested
Gua Sha
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gua ShaOther

Study groups in NCT03333213
Study groupRoleWhat they receive
Gua Sha therapyExperimentalPatients' backs were first covered with Tumarol N Balsam. The study physician then applied a round-edged instrument (the inside smooth edged lip of a metal cap) to patients' skin in downward strokes. Patients were treated twice with a 7-day interval.
Receives: Other: Gua Sha
Waitlist control groupNo interventionTreatments in the control group were not regulated but patients were asked to continue their self-directed medical care. They were offered the Gua Sha therapy once the trial was concluded.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    100-mm visual analogue scale (VAS) ranging from 0mm meaning 'no pain at all' to 100mm meaning 'the worst pain imaginable'

    Measured: 12 weeks

Secondary outcomes (6)
  1. Pain on movement

    Pain on Movement Questionnaire (POM)

    Measured: 12 weeks

  2. Functional disability

    Oswestry Disability Index (ODI)

    Measured: 12 weeks

  3. Pressure-pain threshold (PPT)

    PPT was measured using a digital algometer (Somedic AB, Horby, Sweden).

    Measured: 12 weeks

  4. Mechanical detection threshold (MDT)

    MDT was measured with a set of von Frey filaments (Somedic Sales AB, Horby, Sweden).

    Measured: 12 weeks

  5. Vibration detection threshold (VDT)

    VDT was determined using a Rydel-Seiffer tuning fork (64 Hz, 8/8 scale)

    Measured: 12 weeks

  6. Adverse events

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2017
  2. Study start1 Jan 2009
  3. Primary completion1 Dec 2010
  4. Study completion1 Dec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03333213
Sponsor's protocol ID
08-3594
Status last verified
Nov 2017
First submitted
2 Nov 2017
Last updated
6 Nov 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Gua Sha in people with Low Back Pain, run by Universität Duisburg-Essen.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2017; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in